Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN01115788
ISRCTN01115788
Completed
Phase 2

Melatonin as a novel neuroprotectant in preterm infants - Dosage study

Imperial College London (UK)0 sites24 target enrollmentJune 24, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsTopic: Medicines for Children Research NetworkSubtopic: All DiagnosesDisease: All DiseasesInjury, Occupational Diseases, PoisoningBrain injury

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Topic: Medicines for Children Research Network
Sponsor
Imperial College London (UK)
Enrollment
24
Status
Completed
Last Updated
9 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 24, 2010
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Imperial College London (UK)

Eligibility Criteria

Inclusion Criteria

  • •1\. Infants born at less than 30 weeks gestation, either sex
  • •2\. No major congenital malformation
  • •3\. No cystic periventricular leukomalacia (cPVL) or haemorrhagic parenchymal infarction (HPI) on cranial ultrasonography
  • •4\. Parental consent given
  • •5\. Can begin treatment within 24 hours of birth

Exclusion Criteria

  • •1\. Major congenital malformation
  • •2\. Cystic periventricular leucomalacia (cPVL) or haemorrhagic parenchymal infarcts (HPI) on cranial ultrasonography

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Melatonin as a novel neuroprotectant in preterm infants - trial studyBrain injury in premature babiesNeonatal DiseasesUnspecified brain damage due to birth injury
ISRCTN15119574Imperial College London (UK)60
Active, not recruiting
Phase 1
Melatonin As A Novel Neuroprotectant in Preterm Infants- Dosage study - MIND-Melatonin Neuroprotection Dosage Study
EUCTR2007-007156-33-GBImperial College18
Active, not recruiting
Phase 1
Melatonin As A Novel Neuroprotectant In Preterm Infants-Trial Study - MINT- Melatonin Neuroprotection Trial Study -Ver 1Brain injury from prematurityMedDRA version: 14.0 Level: LLT Classification code 10013384 Term: Disorders relating to short gestation and unspecified low birthweight System Organ Class: 10036585 - Pregnancy, puerperium and perinatal conditions
EUCTR2008-004740-36-GBImperial College, London60
Completed
Phase 2
Melatonin As A Novel Neuroprotectant In Preterm Infants- Dosage StudyPremature BirthBrain Injury
NCT00649961Imperial College London18
Completed
Not Applicable
Oral Melatonin as Neuroprotectant in Preterm InfantsMalondialdehydeMelatonin
NCT04235673Francesca Garofoli60